File(s) not publicly available
P01.035 Nivolumab and Temozolomide (TMZ) vs TMZ alone in newly diagnosed elderly patients (pts) with Glioblastoma (GBM) (NUTMEG): Trial in progress
Version 2 2024-06-13, 13:33
Version 1 2020-02-07, 14:05
journal contribution
posted on 2018-09-19, 00:00 authored by Mustafa Khasraw, K McDonald, S Yip, R G Verhaak, A B Heimberger, M Hall, E Barnes, E Hovey, B M Ellingson, Z LwinP01.035 Nivolumab and Temozolomide (TMZ) vs TMZ alone in newly diagnosed elderly patients (pts) with Glioblastoma (GBM) (NUTMEG): Trial in progress
History
Journal
Neuro-OncologyVolume
20Issue
suppl_3Pagination
iii236 - iii236Publisher
Oxford University Press (OUP)Publisher DOI
ISSN
1522-8517eISSN
1523-5866Language
enPublication classification
E3 Extract of paperUsage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC